Heregulin-induced epigenetic regulation of the utrophin-A promoter

FEBS Letters

Volumn 581, Issue 22, 2007, Pages 4153-4158

  Basu, Utpal ^a   Gyrd Hansen, Mads ^b   Baby, Santhosh M ^a   Lozynska, Olga ^a   Krag, Thomas O B ^a,b   Jensen, Claus J ^c   Frödin, Morten ^c   Khurana, Tejvir S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chromatin remodeling; Heregulin; MSK1 2; Transcription; Utrophin

Indexed keywords

HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEU DIFFERENTIATION FACTOR; SERINE; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; UTROPHIN; UTROPHIN A PROMOTER;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENETIC REGULATION; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENZYME ACTIVATION; EPIGENESIS, GENETIC; HISTONES; MICE; MODELS, GENETIC; MUSCLE CELLS; NEUREGULIN-1; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; UTROPHIN;

EID: 34548133268     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.07.021     Document Type: Article

References (26)

1. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., and Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50 (1987) 509-517
2. Hoffman E.P., Brown R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
3. Love D.R., Hill D.F., Dickson G., Spurr N.K., Byth B.C., Marsden R.F., Walsh F.S., Edwards Y.H., and Davies K.E. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339 (1989) 55-58
4. Khurana T.S., Hoffman E.P., and Kunkel L.M. Identification of a chromosome 6-encoded dystrophin-related protein. Journal of Biological Chemistry 265 (1990) 16717-16720
5. Khurana T.S., Watkins S.C., Chafey P., Chelly J., Tome F.M., Fardeau M., Kaplan J.C., and Kunkel L.M. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscular Disorders 1 (1991) 185-194
6. Burton E.A., Tinsley J.M., Holzfeind P.J., Rodrigues N.R., and Davies K.E. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 14025-14030
7. Gramolini A.O., Angus L.M., Schaeffer L., Burton E.A., Tinsley J.M., Davies K.E., Changeux J.P., and Jasmin B.J. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 3223-3227
8. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., and Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384 (1996) 349-353 (see comments)
9. Deconinck N., Tinsley J., Debacker F., Fisher R., Kahn D., Phelps S., Davies K., and Gillis J.M. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Medicine 3 (1997) 1216-1221
10. Cerletti M., Negri T., Cozzi F., Colpo R., Andreetta F., Croci D., Davies K.E., Cornelio F., Pozza O., Karpati G., Gilbert R., and Mora M. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Therapy 10 (2003) 750-757
11. Chaubourt E., Fossier P., Baux G., Leprince C., Israel M., and De La Porte S. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiology of Disease 6 (1999) 499-507
12. Krag T.O., Bogdanovich S., Jensen C.J., Fischer M.D., Hansen-Schwartz J., Javazon E.H., Flake A.W., Edvinsson L., and Khurana T.S. Heregulin ameliorates the dystrophic phenotype in mdx mice. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 13856-13860
13. Khurana T.S., and Davies K.E. Pharmacological strategies for muscular dystrophy. Nature Reviews Drug Discovery 2 (2003) 379-390
14. Khurana T.S., Rosmarin A.G., Shang J., Krag T.O., Das S., and Gammeltoft S. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta. Molecular Biology of the Cell 10 (1999) 2075-2086
15. Mejat A., Ravel-Chapuis A., Vandromme M., and Schaeffer L. Synapse-specific gene expression at the neuromuscular junction. Annals of the New York Academy of Sciences 998 (2003) 53-65
16. Angus L.M., Chakkalakal J.V., Mejat A., Eibl J.K., Belanger G., Megeney L.A., Chin E.R., Schaeffer L., Michel R.N., and Jasmin B.J. Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction. American Journal of Physiology-Cell Physiology 289 (2005) C908-C917
17. Miura P., and Jasmin B.J. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?. Trends in Molecular Medicine 12 (2006) 122-129
18. Tsukiyama T., and Wu C. Chromatin remodeling and transcription. Current Opinions in Genetics & Development 7 (1997) 182-191
19. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389 (1997) 349-352
20. Davie J.R., and Spencer V.A. Control of histone modifications. Journal of Cellular Biochemistry Suppl. 32-33 (1999) 141-148
21. Davie, J.R. (2003). MSK1 and MSK2 mediate mitogen- and stress-induced phosphorylation of histone H3: a controversy resolved. Science STKE, 2003, PE33.
22. Clayton A.L., and Mahadevan L.C. MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Letters 546 (2003) 51-58
23. Soloaga A., Thomson S., Wiggin G.R., Rampersaud N., Dyson M.H., Hazzalin C.A., Mahadevan L.C., and Arthur J.S. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO Journal 22 (2003) 2788-2797
24. Thompson S., Mahadevan L.C., and Clayton A.L. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Seminars in Cell & Developmental Biology 10 (1999) 205-214
25. Olivieri N.F., and Weatherall D.J. The therapeutic reactivation of fetal haemoglobin. Human Molecular Genetics 7 (1998) 1655-1658
26. Frodin M., Jensen C.J., Merienne K., and Gammeltoft S. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO Journal 19 (2000) 2924-2934